Pharmasund Nordic ApS: Financial statements 2025
CVR: 41686669
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Pharmasund Nordic ApS (CVR 41686669) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 151,397 and a net result of DKK 113,664 compared with DKK 63,921 the year before. That is an increase of 136.8% compared with the year before. Equity in the 2025 report amounted to DKK 26,264. The solvency ratio was 6.2%.
- Gross Profit
- DKK 151,397
- Profit/Loss
- DKK 113,664
- Equity
- DKK 26,264
- Total Assets
- DKK 421,843
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 151K | 114K | 26K | 0 |
| 2024 | - | 64K | 64K | -87K | 0 |
| 2023 | - | - | -77K | -151K | 0 |
| 2022 | - | - | 0 | 50K | - |
Official annual report
How creditworthy is Pharmasund Nordic ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Pharmasund Nordic ApS has published its annual report for 2024. Gross profit came to DKK 63,944, and the net result was DKK 63,921.
About Pharmasund Nordic ApS
Pharmasund Nordic ApS is a Danish company of the type Anpartsselskab based in Søborg, founded in 2020. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Ismail Nayef Ismail Khdeir. The company is owned by P8 Ventures ApS, IDAN Invest ApS and Hjerpsted Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 151,397 and a net result of DKK 113,664 compared with DKK 63,921 the year before. Equity in the 2025 report amounted to DKK 26,264.
